sur Nanohale AG (ETR:FYB)
Formycon Schedules Conference Call and Participation in Investor Conferences
Formycon AG, a German biopharmaceutical company, plans to release its 2026 half-year results on August 12. The Management Board will hold a conference call to discuss the company's progress, financial metrics, and provide future forecasts. The call will be broadcast in English at 3:00 PM CEST. Interested participants are required to register online to receive dial-in details.
In addition to the results announcement, Formycon's executives will participate in various international investor conferences. These events include the H.C. Wainwright Global Investment Conference in New York and the Jefferies London Healthcare Conference, among others.
Formycon continues to engage with investors and stakeholders, emphasizing transparency and dialogue as they advance their biosimilar product portfolio. For access to the live broadcast and more information, visit Formycon's investor relations webpage.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Nanohale AG